Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-399621
Filing Date
2014-11-06
Accepted
2014-11-06 06:31:51
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d804714d10q.htm 10-Q 442376
2 EX-31.1 d804714dex311.htm EX-31.1 10209
3 EX-31.2 d804714dex312.htm EX-31.2 8459
4 EX-32.1 d804714dex321.htm EX-32.1 4519
5 EX-32.2 d804714dex322.htm EX-32.2 4299
  Complete submission text file 0001193125-14-399621.txt   3886107

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgdo-20140930.xml EX-101.INS 449514
7 XBRL TAXONOMY EXTENSION SCHEMA rgdo-20140930.xsd EX-101.SCH 44910
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgdo-20140930_cal.xml EX-101.CAL 52821
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgdo-20140930_def.xml EX-101.DEF 149957
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgdo-20140930_lab.xml EX-101.LAB 351855
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgdo-20140930_pre.xml EX-101.PRE 232743
Mailing Address 120 MOUNTAIN VIEW BOULEVARD BASKING RIDGE NJ 00000
Business Address 120 MOUNTAIN VIEW BOULEVARD BASKING RIDGE NJ 00000 908.580.2111
Regado Biosciences Inc (Filer) CIK: 0001311596 (see all company filings)

EIN.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35953 | Film No.: 141198706
SIC: 2834 Pharmaceutical Preparations